v3.25.4
Financial Instruments (Tables)
 12 Months Ended
Jan. 03, 2026
Investments, All Other Investments [Abstract]  
Schedule of Fair Values of Derivative Instruments Included within Accompanying Consolidated Balance Sheets The fair values of derivative instruments included within the accompanying Consolidated Balance Sheets as of 2025 and 2024 year end are as follows:
  20252024
(Amounts in millions)Balance Sheet
Presentation		Derivative
Assets
Fair Value		Derivative
Liability
Fair Value		Derivative
Assets
Fair Value		Derivative
Liability
Fair Value
Derivatives not designated as hedging instruments:
Foreign currency forwardsPrepaid expenses and
 other current assets		$7.5 $— $12.3 $— 
Foreign currency forwardsOther accrued liabilities— 9.6 — 21.3 
Equity forwardsPrepaid expenses and
 other current assets		25.6 — 23.4 — 
Total derivative instruments$33.1 $9.6 $35.7 $21.3 
Schedule of Effect of Cash Flow Hedges Included in the Consolidated Statements of Earnings
The effect of cash flow hedges included in the Consolidated Statements of Earnings is as follows: 
Gain (Loss) Recognized in Income on
Cash Flow Hedging Relationships
202520242023
(Amounts in millions)
The amount of interest expense presented in the Consolidated Statements of Earnings:$(50.5)$(49.6)$(49.9)
Gain on cash flow hedging relationships:
Treasury locks
Gain reclassified from accumulated OCI into income
$1.7 $1.7 $1.6 
Schedule of Derivative Instruments Not Designated as Hedges Included in Consolidated Statements of Earnings
The effects of derivative instruments not designated as hedging instruments as included in the Consolidated Statements of Earnings are as follows: 
Statement of
Earnings
Presentation		Gain (Loss) Recognized in
Income on Derivatives
(Amounts in millions)202520242023
Gain (loss) on derivative relationships:
Foreign currency forwards
Other income
  (expense) –  net    		$(25.1)$(9.1)$6.0 
Net exposures
Other income
  (expense) –  net    		21.5 1.7 (17.0)
Equity forwards
Operating expenses$(1.2)$4.8 $4.5 
Stock-based deferred compensation liabilities
Operating expenses0.7 (4.5)(4.5)
Schedule of Fair Values of Financial Instruments Not Approximating Carrying Values in Financial Statements The fair values of financial instruments that do not approximate the carrying values in the financial statements as of 2025 and 2024 year end are as follows: 
 20252024
(Amounts in millions)Carrying
Value		Fair
Value		Carrying
Value		Fair
Value
Finance receivables – net$1,889.0 $2,166.0 $1,922.3 $2,180.9 
Contract receivables – net553.1 593.4 538.3 569.5 
Long-term debt and notes payable
1,202.6 967.8 1,199.2 944.2